Clarivate (CLVT) Q4 2025 Earnings Call Summary
Clarivate (CLVT) reported positive financial results for Q4 2025, meeting its full-year guidance for the first time since 2019. The company is focusing on accelerating organic ACV and free cash flow growth, with plans to sell its Life Sciences & Health business to enhance value creation. The CEO emphasized confidence in the company's AI-enhanced proprietary solutions and stable revenue retention.
Topics: AI Integration Business Portfolio Earnings Call Financial Performance Free Cash Flow Revenue Retention Strategic Review